← FDATracker
HomeAdverse Events

ENBREL Adverse Event: Neoplasm malignant

ENBREL Adverse Event: Neoplasm malignant is one of 4,500 adverse events in the FDATracker dataset. Key details — Primary drug: ENBREL; Product category: Drug; Primary reaction: Neoplasm malignant.

Primary drugENBREL
Product categoryDrug
Primary reactionNeoplasm malignant
All reactionsNeoplasm malignant
SeriousnessSerious
Patient outcomeUnknown
Patient sexFemale
All drugs reportedENBREL
Reporter countryCA
Reporter type5
Report date20140313
Report ID10006531

🔍 Search all adverse events →